(Q34674697)

English

Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Marshall J Glesby

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jeanine Albu

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ya-Lin Chiu

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kirsis Ham

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ellen Engelson

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Qing He

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Varalakshmi Muthukrishnan

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Henry N Ginsberg

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Daniel Donovan

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jerry Ernst

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Martin Lesser

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Donald P Kotler

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

12 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

e61160

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

12 April 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Rosiglitazone, myocardial ischemic risk, and recent regulatory actions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Management of the metabolic effects of HIV and HIV drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Measurement of extracellular water volume by bromide ion chromatography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

7 July 2018

Growth hormone (GH) responses to GH-releasing hormone-arginine testing in human immunodeficiency virus lipodystrophy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Repeatability of insulin sensitivity and glucose effectiveness from the minimal model. Implications for study design

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Metabolic effects of a growth hormone-releasing factor in patients with HIV.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0061160

21 January 2018

Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety e

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

26 October 2018

Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625151

26 October 2018

A simple, inexpensive method of determining total body water using a tracer dose of D2O and infrared absorption of biological fluids

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratum

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of troglitazone on body fat distribution in type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection of anthropometric indicators for classification of abdominal fatness--a critical review

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/23593417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0061160

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2013PLoSO...861160G

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34674697&oldid=1865090879"